Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.

Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.

Item
http://www.wikidata.org/entity/Q40160745
An Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence.Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys.Preventing invasive salmonellosis in children through vaccination.Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.Usefulness of the serial measurement of Vi antibodies.The Gathering Storm: Is Untreatable Typhoid Fever on the Way?Case fatality rate of enteric fever in endemic countries: A systematic review and meta-analysis.Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts.Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological biasEstablishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG
P2860

Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.

Item
http://www.wikidata.org/entity/Q40160745
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and immunogenicity of a ...... ized controlled phase 3 study.
@en
type
label
Safety and immunogenicity of a ...... ized controlled phase 3 study.
@en
prefLabel
Safety and immunogenicity of a ...... ized controlled phase 3 study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Safety and immunogenicity of a ...... ized controlled phase 3 study.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921